A

Safety Data of Brentuximab Vedotin in cHL and Management of Adverse Reactions: A Focus on Peripheral Neuropathy

By Anna Sureda 3 Videos
472 views
August 30, 2022
1 Comment
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
18:26
William Schaffner

Shingles (Herpes Zoster) Vaccination in Adults: What is the Importan…

21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
11:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…

Feat. A. Herrera
15:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826 - Rationale, Results, and Clin…

Feat. A. Evens
10:04
Stephen M. Ansell

NCCN Guidelines for the Treatment of cHL: A New Standard of Care

40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
08:59
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "SWOG S1826 Trial - Nivo-AVD vs. Bv-AVD in O…

Feat. S. Rutherford
41:20
SOHO Highlights: State of the Art and Next Questions

SOHO Highlights - State of the Art & Next Questions: Hodgkin Lym…

Feat. N. Bartlett
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
15:18
UNC Lineberger Comprehensive Cancer Center

Hodgkin Lymphoma Management: Updates for 2023

Feat. N. Grover
40:13
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Diagnosis and Treatment of Hodgkin's Lymphoma

Feat. R. C. Lynch
21:26
Hackensack Meridian John Theurer Cancer Center

A+AVD in Frontline cHL: Barriers and Challenges

Feat. T. Feldman
30:24
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment of Older Patients With HL in the …

Feat. A. Evens
42:09
University of Colorado Department of Medicine

Immunotherapy in Lymphomas: The Present and the Future

Feat. M. Kamdar
28:57
Total Health

Highlights From Key Hematology Trials at ASCO® 2023

Feat. J. Strauss
27:47
City of Hope

Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Ta…

Feat. I. Amanam
15:24
Total Health

2023 ASCO® Direct Philadelphia: Hodgkin Lymphoma Updates

Feat. J. Svoboda
23:24
SOHO Brazil 2023

2023 SOHO® Brazil: "How I Sequence New Agents in First and Seco…

Feat. A. Moskowitz